Core Viewpoint - The company reported strong financial performance in H1 2025, driven by increased sales of catalyst products and structural changes in its business model [1] Group 1: Financial Performance - In H1 2025, the company achieved revenue, net profit attributable to shareholders, and net profit excluding non-recurring gains and losses of 1.014 billion, 61 million, and 63 million yuan respectively, representing year-on-year increases of 24.86%, 30.83%, and 48.74% [1] - In Q2 2025, the company recorded revenue, net profit attributable to shareholders, and net profit excluding non-recurring gains and losses of 389 million, 39 million, and 40 million yuan respectively, with year-on-year changes of -23.42%, +11.38%, and +15.47% [1] Group 2: Business Segments - The sales volume in the basic chemical sector increased by 185.5% year-on-year, primarily due to a 113.2% increase in sales of mercury-free PVC catalysts, along with the introduction of multiple basic chemical catalysts to the market [1] - The pharmaceutical segment saw a sales increase of 49.3% year-on-year, driven by increased demand from core customers and an improvement in market share [1] - The environmental and new energy segment experienced a staggering 1497.1% increase in sales year-on-year, attributed to significant progress in hydrogen catalysts and partnerships with leading companies in water electrolysis hydrogen production [1] Group 3: Future Outlook - The company is expected to maintain an upward trend in its fundamentals, with significant breakthroughs in key customer orders for PVC products anticipated in the second half of 2024 [2] - The company has a backlog of 461 tons of orders for PVC products as of the end of Q1 2025, which is expected to support high growth in sales and revenue for the basic chemical sector throughout the year [2] - The HNBR (hydrogenated nitrile butadiene rubber) industrialization project is expected to launch in the second half of 2025, which could lead to a significant improvement in production efficiency and product quality, positioning the company as a leader in the domestic high-end HNBR market [2] Group 4: Profit Forecast and Investment Recommendation - The company is projected to achieve net profits attributable to shareholders of 170 million, 236 million, and 268 million yuan for 2025-2027, representing year-on-year growth rates of 83.51%, 38.66%, and 13.67% respectively [3] - The current price-to-earnings ratios corresponding to these profit forecasts are 30.8, 22.2, and 19.5 times [3] - The company is expected to exhibit strong performance due to rising prices of key raw materials, increased production in the basic chemical sector, and a recovery in the pharmaceutical sector, leading to a favorable profit growth outlook [3]

Core Viewpoint - The company is experiencing significant growth in catalyst sales, with a record high revenue in Q1 2025, driven by new product launches and strong customer relationships [1][2]. Group 1: Sales Performance - In 2024, overall catalyst sales reached 597 tons, a year-on-year increase of 60.21%, with pharmaceutical sales up 71.79%, new chemical materials up 173.82%, and basic chemicals up 47.28% [2]. - Q1 2025 saw catalyst sales increase by 188.87% year-on-year, with pharmaceutical and basic chemical sales growing by 174.88% and 285.6%, respectively [2]. Group 2: Price Dynamics - The average price of palladium, a key raw material, was 260.49 yuan/kg in 2024, down 24.79% year-on-year, while the overall sales price of catalysts fell to 2384.43 yuan/kg, a decrease of 44.58% [2]. - Palladium prices are expected to stabilize between $800 and $1,200 per ounce in 2025, which will create a more favorable environment for business operations compared to the significant price drops in 2023-2024 [3]. Group 3: New Products and Contracts - By the end of 2024, the company's contract liabilities reached 0.35 billion yuan, an increase of 0.27 billion yuan year-on-year, indicating a rise in business volume under a payment-on-delivery model [4]. - The HNBR (hydrogenated nitrile butadiene rubber) project is under construction and is expected to launch in the second half of 2025, utilizing low-cost catalytic hydrogenation technology [4]. Group 4: Profit Forecast and Valuation - The company forecasts net profits of 170 million yuan, 236 million yuan, and 268 million yuan for 2025-2027, representing year-on-year growth of 83.51%, 38.66%, and 13.67%, respectively [5]. - The stable raw material prices and increased catalyst sales are expected to enhance profit elasticity in 2025, supported by the release of contract liabilities and new product volumes [5].